Raymond James Financial (NYSE: RJF) insider transactions
In the twelve months to 10 November 2026, executives and directors of Raymond James Financial reported 8 open-market sales of 188,008 shares ($30.4m) and 0 open-market purchases, by 5 people, according to the Form 4 filings they submitted to the SEC.
Latest transactions
| Date | Insider | Role | Transaction | Shares | Price | Held after | Filing |
|---|---|---|---|---|---|---|---|
| 28 August 2026 | Allaire Bella Loykhter | Chief Admin Officer | Open-market sale | −7,500 | $177.60 | 46,086 | Form 4 |
| 20 August 2026 | Helal Tarek | Chief Strategy Officer | Gift | +23,397 | — | 48,537 | Form 4 |
| 20 August 2026 | Helal Tarek | Chief Strategy Officer | Gift | −23,397 | — | 25,140 | Form 4 |
| 18 August 2026 | Curtis Scott A | Chief Operating Officer | Gift | −1,000 | — | 191,418 | Form 4 |
| 28 July 2026 | Elwyn Tashtego S | President, PCG | Open-market sale | −10,000 | $176.06 | 45,114 | Form 4 |
| 27 July 2026 | Raney Steven M | Executive Chair RJBank | Open-market sale | −5,770 | $172.97 | 43,046 | Form 4 |
| 19 March 2026 | Allaire Bella Loykhter | Chief Admin Officer | Open-market sale | −29,551 | $142.34 | 53,586 | Form 4 |
| 28 February 2026 | Aisenbrey Christopher S | Chief Human Resources Officer | Option exercise | +600 | — | 17,622 | Form 4 |
| 28 February 2026 | Aisenbrey Christopher S | Chief Human Resources Officer | Shares withheld for tax | −132 | $153.08 | 17,490 | Form 4 |
| 24 February 2026 | Edwards Jeffrey N | Director | Gift | −1,504 | — | 9,533 | Form 4 |
| 24 February 2026 | Edwards Jeffrey N | Director | Gift | +1,504 | — | 22,008 | Form 4 |
| 19 February 2026 | Begor Mark W | Director | Grant or award | +1,303 | — | 2,285 | Form 4 |
| 19 February 2026 | Debel Marlene | Director | Option exercise | +1,253 | — | 8,820 | Form 4 |
| 19 February 2026 | Edwards Jeffrey N | Director | Option exercise | +1,253 | — | 11,037 | Form 4 |
| 19 February 2026 | Mistarz Cecily | Director | Grant or award | +1,303 | — | 2,489 | Form 4 |
| 19 February 2026 | Mistarz Cecily | Director | Option exercise | +1,253 | — | 3,742 | Form 4 |
| 19 February 2026 | Mistarz Cecily | Director | Option exercise | +250 | — | 3,992 | Form 4 |
| 19 February 2026 | Mistarz Cecily | Director | Option exercise | +250 | — | 4,242 | Form 4 |
| 19 February 2026 | Esty Benjamin | Director | Grant or award | +1,303 | — | 31,794 | Form 4 |
| 19 February 2026 | Garcia Art A | Director | Grant or award | +1,303 | — | 6,992 | Form 4 |
Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.
How to read the table
Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.
Where each row comes from
From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Raymond James Financial page; the method, in data sources.
Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.